aubagio
sanofi winthrop industrie - teriflunomide - multiple skleroza - selektivni imunosupresivi - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
amaryl 4 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 4 mg / 1 tableta - glimepirid
amaryl 1 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 1 mg / 1 tableta - glimepirid
amaryl 6 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 6 mg / 1 tableta - glimepirid
amaryl 3 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 3 mg / 1 tableta - glimepirid
amaryl 2 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 2 mg / 1 tableta - glimepirid
bloonis 10 mg orodisperzibilne tablete
sanofi-aventis d.o.o. - olanzapin - orodisperzibilna tableta - olanzapin 10 mg / 1 tableta - olanzapin
bloonis 15 mg orodisperzibilne tablete
sanofi-aventis d.o.o. - olanzapin - orodisperzibilna tableta - olanzapin 15 mg / 1 tableta - olanzapin
bloonis 5 mg orodisperzibilne tablete
sanofi-aventis d.o.o. - olanzapin - orodisperzibilna tableta - olanzapin 5 mg / 1 tableta - olanzapin
bloonis 10 mg filmsko obložene tablete
sanofi-aventis d.o.o. - olanzapin - filmsko obložena tableta - olanzapin 10 mg / 1 tableta - olanzapin